CDEK
← All drugs Report issue

hx008

mAbexperimental

Clinical trial activity

36 trials · 27 clinical orgs · 0 marketing orgs

Phase 1
9
Phase 2
30
Phase 3
5
Phase 4
0

Earliest trial started Sep 30, 2018 (NCT03704246)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06959108Phase 2Oct 31, 2025Groupe Oncologie Radiotherapie Tete et Cou, GROUPE ONCOLOGIE RADIOTHERAPIE TETE ET COU, Lepu Medical Technology (Beijing) Co., Ltd.
NCT07054307Phase 1Jul 30, 2025Lepu Medical Technology (Beijing) Co., Ltd., Sichuan University
NCT06976190Phase 3May 31, 2025Shanghai Miracogen Inc., Sun Yat-Sen University
NCT06969534Phase 2May 15, 2025Sun Yat-Sen University
NCT06895369Phase 2May 1, 2025Zhejiang University
NCT07235566Phase 2Apr 21, 2025Fudan University
NCT07188311N/AApr 10, 2025Sun Yat-Sen University
NCT06872606Phase 2Apr 1, 2025Zhejiang University
NCT06869174Phase 2Mar 8, 2025Fudan University
NCT06770270Phase 2Jan 3, 2025Zhejiang University
NCT06561308Phase 2Sep 1, 2024Anhui Medical University, Central South University, Chinese Academy of Medical Sciences, Henan Provincal People's Hospital, Huazhong University of Science and Technology, Ningbo No. 1 Hospital, Shandong University, University of Electronic Science and Technology of China, Wenzhou Medical University, Zhejiang University, Zhengzhou University
NCT06530914Phase 2Aug 1, 2024Sichuan University
NCT06524466Phase 2Jul 23, 2024Sun Yat-Sen University
NCT06192797Phase 2Jun 11, 2024Huazhong University of Science and Technology
NCT06456892Phase 1/Phase 2 (Phase 2)Jun 6, 2024Sun Yat-Sen University
NCT06192784Phase 2Dec 9, 2023Geneplus-Beijing Co. Ltd., Government of China, Huazhong University of Science and Technology
NCT06129955Phase 2Nov 11, 2023Sun Yat-Sen University
NCT05647954Phase 3Dec 31, 2022Peking University, Taizhou Hanzhong biomedical co. LTD
NCT05652894Phase 3Dec 20, 2022Taizhou Hanzhong biomedical co. LTD
NCT05338957Phase 1/Phase 2 (Phase 2)Aug 5, 2022Shanghai Miracogen Inc., Shanghai Oriental Hospital
Showing 20 of 36 trials
Page 1 / 2

Organizations

Research & Development (27)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Taizhou Hanzhong biomedical co. LTDGovernment111132018
Sun Yat-Sen UniversityAcademic/Hospital7532022
Fudan UniversityAcademic/Hospital4312019
Zhejiang UniversityAcademic/Hospital4412024
Huazhong University of Science and TechnologyAcademic/Hospital3212023
Shanghai Miracogen Inc.For profit3322022
Chinese Academy of Medical SciencesAcademic/Hospital2112021
Government of ChinaGovernment2122020
Lepu Medical Technology (Beijing) Co., Ltd.For profit2022025
Peking UniversityAcademic/Hospital2022018
Sichuan UniversityAcademic/Hospital2222024
Wuhan Binhui Biotechnology Co., Ltd.For profit2222019
Anhui Medical UniversityAcademic/Hospital1012024
Central South UniversityAcademic/Hospital1012024
Geneplus-Beijing Co. Ltd.For profit1012023
Groupe Oncologie Radiotherapie Tete et CouAcademic/Hospital1112025
GROUPE ONCOLOGIE RADIOTHERAPIE TETE ET COUAcademic/Hospital1012025
Guangzhou Medical UniversityAcademic/Hospital1012021
Henan Provincal People's HospitalAcademic/Hospital1012024
Jiao Tong UniversityAcademic/Hospital1112019
27 organizations
Page 1 / 2